Swarajya

Our View
HeadlinesMagazineVideosBooksस्वराज्यEconomyCultureEvents
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief
  • Subscriber login
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief

mRNA vaccine

AstraZeneca Vaccine Behind Lower Covid Deaths In UK Compared To EU Nations As It Offers Stronger Long-term Protection, Says Expert
AstraZeneca Vaccine Behind Lower Covid Deaths In UK Compared To EU Nations As It Offers Stronger Long-term Protection, Says Expert PTIDec 27, 2021 06:57 PM +05:30 IST
Shanghai-Based Biopharma Strikes Deal With Canadian Firm To Bring mRNA Covid Vaccine In China
Shanghai-Based Biopharma Strikes Deal With Canadian Firm To Bring mRNA Covid Vaccine In ChinaBhaswati Guha Majumder Sep 14, 2021 05:16 PM +05:30 IST
India’s Biological E Will Make mRNA Covid Vaccine Developed By Canada’s Providence Therapeutics
India’s Biological E Will Make mRNA Covid Vaccine Developed By Canada’s Providence Therapeutics Bhaswati Guha Majumder Jun 2, 2021 07:30 PM +05:30 IST
Centre, Pfizer Working Together For Earliest Possible Import Of COVID-19 Vaccine, Says Govt's Expert Panel Head V K Paul
Centre, Pfizer Working Together For Earliest Possible Import Of COVID-19 Vaccine, Says Govt's Expert Panel Head V K PaulSwarajya StaffMay 27, 2021 03:36 PM +05:30 IST
Pfizer Offers Government A "Not-For-Profit" Price For Roll-Out Of Its Two-Dose mRNA COVID-19 Vaccine In India
Pfizer Offers Government A "Not-For-Profit" Price For Roll-Out Of Its Two-Dose mRNA COVID-19 Vaccine In IndiaSwarajya StaffApr 23, 2021 08:44 AM +05:30 IST
Pune-Based Gennova Set To Begin Clinical Trials Of India's First mRNA Covid-19 Vaccine This Month
Pune-Based Gennova Set To Begin Clinical Trials Of India's First mRNA Covid-19 Vaccine This MonthSwarajya StaffApr 10, 2021 10:53 AM +05:30 IST
 Moderna To Seek ‘Emergency Use Authorisation’ From US And European Regulators For Covid-19 Vaccine, Efficacy At 94.1%
Moderna To Seek ‘Emergency Use Authorisation’ From US And European Regulators For Covid-19 Vaccine, Efficacy At 94.1%Swarajya StaffNov 30, 2020 08:34 PM +05:30 IST
President Trump Announces A $1.5 billion Deal with Moderna For 100 Million Doses of Coronavirus Vaccine  
President Trump Announces A $1.5 billion Deal with Moderna For 100 Million Doses of Coronavirus Vaccine  Swarajya StaffAug 12, 2020 12:07 PM +05:30 IST
US Government Backed Moderna’s Coronavirus Vaccine Begins Phase 3 Final-Stage Testing, 30000 People To Be Dosed
US Government Backed Moderna’s Coronavirus Vaccine Begins Phase 3 Final-Stage Testing, 30000 People To Be DosedSwarajya StaffJul 27, 2020 08:19 PM +05:30 IST
US-Based Moderna's Covid-19 Vaccine Clears Safety Test In Mouse Study, Final-Stage Testing On 30,000 People To Begin In July
US-Based Moderna's Covid-19 Vaccine Clears Safety Test In Mouse Study, Final-Stage Testing On 30,000 People To Begin In JulySwarajya StaffJun 13, 2020 09:25 AM +05:30 IST
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Advertise
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype